Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Pernot

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
La Revue Du Praticien|March 15, 2019
[A drug-resistant dyspepsia]Thibault Voron, Simon Pernot
Bulletin Du Cancer|May 1, 2021
[New European approvals: Pemigatinib - cholangiocarcinoma with a FGFR2 fusion or rearrangement]Matthieu Delaye, Simon Pernot
Current Opinion in Oncology|May 4, 2016
Checkpoint inhibitors and gastrointestinal immune-related adverse eventsSimon Pernot, Toulsie Ramtohul, Julien Taieb
Bulletin Du Cancer|April 13, 2021
[Sequential therapeutic strategy: Promises and difficulties]Serge Évrard, Simon Pernot, Majid Khatib
Bulletin Du Cancer|November 12, 2022
[Oesogastric cancer - new therapeutic targets]Lola-Jade Palmieri, Isabelle Soubeyran, Simon Pernot
Frontiers in Immunology|May 2, 2022
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and RepressionSimon Pernot, Serge Evrard, Abdel-Majid Khatib
Drugs|May 24, 2018
Colorectal Cancer: Why Does Side Matter?Claire Gallois, Simon Pernot, Aziz Zaanan, et al.
British Journal of Cancer|April 29, 2016
Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'Simon Pernot, Jean-Baptiste Bachet, Alix Portal, et al.
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspectsSimon Pernot, Magali Terme, Aziz Zaanan, et al.
Cardiovascular and Interventional Radiology|April 12, 2014
Microvascular plug: a new embolic material for hepatic arterial skeletonizationOlivier Pellerin, Geert Maleux, Carole Déan, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
La Revue Du Praticien|March 15, 2019
[A drug-resistant dyspepsia]Thibault Voron, Simon Pernot
Bulletin Du Cancer|May 1, 2021
[New European approvals: Pemigatinib - cholangiocarcinoma with a FGFR2 fusion or rearrangement]Matthieu Delaye, Simon Pernot
Current Opinion in Oncology|May 4, 2016
Checkpoint inhibitors and gastrointestinal immune-related adverse eventsSimon Pernot, Toulsie Ramtohul, Julien Taieb
Bulletin Du Cancer|April 13, 2021
[Sequential therapeutic strategy: Promises and difficulties]Serge Évrard, Simon Pernot, Majid Khatib
Bulletin Du Cancer|November 12, 2022
[Oesogastric cancer - new therapeutic targets]Lola-Jade Palmieri, Isabelle Soubeyran, Simon Pernot
Frontiers in Immunology|May 2, 2022
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and RepressionSimon Pernot, Serge Evrard, Abdel-Majid Khatib
Drugs|May 24, 2018
Colorectal Cancer: Why Does Side Matter?Claire Gallois, Simon Pernot, Aziz Zaanan, et al.
British Journal of Cancer|April 29, 2016
Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'Simon Pernot, Jean-Baptiste Bachet, Alix Portal, et al.
Clinics and Research in Hepatology and Gastroenterology|August 13, 2013
Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspectsSimon Pernot, Magali Terme, Aziz Zaanan, et al.
Cardiovascular and Interventional Radiology|April 12, 2014
Microvascular plug: a new embolic material for hepatic arterial skeletonizationOlivier Pellerin, Geert Maleux, Carole Déan, et al.
Pageof 11